Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 216

The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.

Different effects of bisphosphonate and estrogen therapy on free and peptide-bound bone cross-links excretion

Garnero, Patrick, Gineyts, Evelyne, Arbault, Patrice, Christiansen, Claus, Delmas, Pierre D.·1995·Journal of Bone and Mineral Research

Abstract

We have measured the free and peptide-bound type I collagen cross-link excretions in normal women and in patients with metabolic bone disease using the HPLC technique and immunoassays recognizing specifically the free or peptide-bound forms of pyridinoline (Pyr). After menopause, free deoxypyridinoline (free D-Pyr) excretion measured by HPLC without urine hydrolysis and expressed as a fraction of the total excretion was lower than in premenopausal women (45 ± 15% vs. 59 ± 12%, p > 0.005), whereas the fraction of free Pyr was not changed. In normal pre- and postmenopausal women (n = 43), the fraction of free D-Pyr was negatively correlated with bone turnover rate as assessed by the total urinary excretion of Pyr (r = –0.64, p > 0.001). In patients with a variety of metabolic bone diseases characterized by increased bone turnover (osteoporosis, Paget's disease, and hyperthyroidism), the fractions of free Pyr and free D-Pyr were significantly lower than in premenopausal controls (p > 0.001 for all diseases). After 3 days of intravenous (iv) treatment with the bisphosphonate pamidronate in patients with Paget's disease and osteoporosis, the urinary excretion of cross-linked peptides measured by high performance liquid chromatography (HPLC) or enzyme-linked immunoassay (ELISA) (NTX and CrossLaps) was markedly decreased (–52% and –85% for NTX, –71% and –93% for CrossLaps™ in Paget's disease and osteoporosis, respectively). The excretion of total cross-links was decreased to a lesser extent after treatment (–25% and –25% for total Pyr, –37% and –45% for total D-Pyr) and, surprisingly, free cross-links measured either by HPLC without urine hydrolysis or with an ELISA specific for free D-Pyr were unchanged after treatment. In contrast to bisphosphonate therapy, estrogen treatment of postmenopausal women decreased not only total and cross-linked peptides but also the free cross-link excretion that was reduced by about 30–40%. The different effects of bisphosphonate and estrogen therapy on the excretion of peptide-bound and free cross-link excretion were confirmed by gel filtration of the urine on Sephadex G 25 before and after treatment. In conclusion, we have shown that increased bone turnover in patients with metabolic bone disease could result in a larger increase of the urinary excretion of cross-linked peptides over the increase of free cross-links. Bisphosphonate therapy decreased markedly cross-linked peptides without significant change in free cross-link excretion contrasting with a decrease of both free and peptide-bound cross-links after estrogen therapy. These data suggest that these two antiresorptive therapies may affect differently the pattern of bone collagen degradation, an intriguing possibility that should be further investigated in vitro.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1002/jbmr.5650100418

Cites

2 of 2 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 2 references

Cited by

See all 216

Metadata

Authors
Garnero, P., Gineyts, E., Arbault, P., Christiansen, C., & Delmas, P. D.
Venue
Journal of Bone and Mineral Research
Published
1995-04-01
Volume
10
Issue
4
Pages
641-649
ISSN
  • 0884-0431 (ISSN-L)
  • 1523-4681
OpenAlex
W1975606701
Cited by
216
References
2
FWCI
29.39
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Different effects of bisphosphonate and estrogen therapy on free and peptide-bound bone cross-links excretion. https://app.cochat.ai/papers/10.1002/jbmr.5650100418
The paper
Garnero, P., Gineyts, E., Arbault, P., Christiansen, C., & Delmas, P. D. (1995). Different effects of bisphosphonate and estrogen therapy on free and peptide-bound bone cross-links excretion. Journal of Bone and Mineral Research. https://doi.org/10.1002/jbmr.5650100418

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.